
Thursday, June 26 8:30–9:30am
Brain Check: Promoting Brain Health and Detecting Cognitive Impairment

Thursday, June 26 8:30–9:30am
Brain Check: Promoting Brain Health and Detecting Cognitive Impairment

Thursday, June 26 1:30–2:30pm
Skin Deep: Tackling Everyday Dermatologic Cases in Primary Care

Thursday, June 26 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity

Thursday, June 26 3:30–4:15pm
Breakthroughs in Psychiatry: Emerging Treatments for Common Disorders

Thursday, June 26 7:30–8:30am
Thursday, June 26 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity

Friday, June 27 10:30–11:30am
Cardiology in Focus: Breaking Down the Latest Guideline Updates
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Andrew E. Budson, MD
- Eli Lilly and AbbVie, Advisor; Vox Neuro and Bristol Meyers Squibb, Independent Contractor
- Amy Clouse, MD, FAAFP
- Astellas Pharmacueticals, Speaker; Eli Lilly; Novo Nordisk, Stock Holder (publicly traded company)
- Katherine E. Galluzzi, DO, CMD, FACOFP
- No relevant financial relationships disclosed.
- Stephen N. Henry, DO, MS
- No relevant financial relationships disclosed.
- Jennifer A. Johnson, MD
- No relevant financial relationships disclosed.
- Pamela Kushner, MD, FAAFP
- GlaxoSmithKline, Novo Nordisk, AstraZeneca, Lilly, Abbott, Haleon, Bausch/SALIX, Corcept, Boehringer Ingelheim, Advisor; Novo Nordisk, Lilly, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Abbott, Phathom, Bausch/SALIX, Intuity, Pfizer, and Janssen., Speaker
- Avery Lachance, MD, MPH
- Guidepoint, Consultant; J&J, Consultant; Merck, Researcher; Pfizer, Consultant; Pfizer, Researcher; TD Cowen, Advisor
- Joynita R. Nicholson, DO, DABOM, FOMA
- No relevant financial relationships disclosed.
- Vani Potluri, MD
- No relevant financial relationships disclosed
- Jeffrey Rado, MD, MPH, FAPA
- Alkermes, Speaker; Cerevel, Neurorelief, NRX Pharmaceuticals, Researcher; Paraxel, Consultant
- Philip Schoenfeld, MD, MSEd, MSc
- Ironwood Pharmaceuticals, Ardelyx Pharmaceuticals, Phathom Pharmaceuticals, AbbVie Pharmaceuticals, Speaker; Phathom Pharmaceuticals, Ardelyx Pharmaceuticals, Consultant
- Chrisandra L. Shufelt, MD, MS, FACP, MSCP
- Bayer, Novo Nordisk, Advisor
- Charles Vega, MD, FAAFP
- Boehringer Ingelheim, and Exact Sciences, Consultant
- Karol E. Watson, MD, PhD
- Amarin, Consultant; Amgen, Consultant; Boehringer Ingelheim, Consultant; Eli Lilly, Consultant; Novartis, Consultant
- Gloria Y. Yeh, MD, MPH
- Information to come
Other Disclosures
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.